Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor
- PMID: 24477544
- DOI: 10.1152/ajpregu.00495.2013
Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor
Abstract
Glucagon-like peptide 1 receptors (GLP-1R) are expressed in multiple tissues and activation results in metabolic benefits including enhanced insulin secretion, slowed gastric emptying, suppressed food intake, and improved hepatic steatosis. Limited and inconclusive knowledge exists regarding whether the effects of chronic exposure to a GLP-1R agonist are solely mediated via this receptor. Therefore, we examined 3-mo dosing of exenatide in mice lacking a functional GLP-1R (Glp1r(-/-)). Exenatide (30 nmol · kg(-1) · day(-1)) was infused subcutaneously for 12 wk in Glp1r(-/-) and wild-type (Glp1r(+/+)) control mice fed a high-fat diet. Glycated hemoglobin A1c (HbA1c), plasma glucose, insulin, amylase, lipase, alanine aminotransferase (ALT), aspartate aminotransferase (AST), body weight, food intake, terminal hepatic lipid content (HLC), and plasma exenatide levels were measured. At the end of the study, oral glucose tolerance test (OGTT) and rate of gastric emptying were assessed. Exenatide produced no significant changes in Glp1r(-/-) mice at study end. In contrast, exenatide decreased body weight, food intake, and glucose in Glp1r(+/+) mice. When compared with vehicle, exenatide reduced insulin, OGTT glucose AUC0-2h, ALT, and HLC in Glp1r(+/+) mice. Exenatide had no effect on plasma amylase or lipase levels. Exenatide concentrations were approximately eightfold higher in Glp1r(-/-) versus Glp1r(+/+) mice after 12 wk of infusion, whereas renal function was similar. These data support the concept that exenatide requires a functional GLP-1R to exert chronic metabolic effects in mice, and that novel "GLP-1" receptors may not substantially contribute to these changes. Differential exenatide plasma levels in Glp1r(+/+) versus Glp1r(-/-) mice suggest that GLP-1R may play an important role in plasma clearance of exenatide and potentially other GLP-1-related peptides.
Keywords: GLP-1 receptor knockout; clearance; mice.
Similar articles
-
Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for beta cell survival in mice.Gastroenterology. 2009 Dec;137(6):2146-57. doi: 10.1053/j.gastro.2009.09.004. Epub 2009 Sep 17. Gastroenterology. 2009. PMID: 19766644
-
Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes.Obesity (Silver Spring). 2011 Dec;19(12):2310-5. doi: 10.1038/oby.2011.152. Epub 2011 Jun 9. Obesity (Silver Spring). 2011. PMID: 21660077 Clinical Trial.
-
No evidence of drug-induced pancreatitis in rats treated with exenatide for 13 weeks.Diabetes Obes Metab. 2013 May;15(5):417-26. doi: 10.1111/dom.12040. Epub 2012 Dec 7. Diabetes Obes Metab. 2013. PMID: 23163898 Free PMC article.
-
An overview of once-weekly glucagon-like peptide-1 receptor agonists--available efficacy and safety data and perspectives for the future.Diabetes Obes Metab. 2011 May;13(5):394-407. doi: 10.1111/j.1463-1326.2011.01357.x. Epub 2011 Jan 5. Diabetes Obes Metab. 2011. PMID: 21208359 Review.
-
Differential effects of GLP-1 receptor agonists on components of dysglycaemia in individuals with type 2 diabetes mellitus.Diabetes Metab. 2013 Dec;39(6):485-96. doi: 10.1016/j.diabet.2013.09.004. Epub 2013 Oct 22. Diabetes Metab. 2013. PMID: 24156868 Review.
Cited by
-
Transforming Diabetes Care: The Molecular Pathways through Which GLP1-RAs Impact the Kidneys in Diabetic Kidney Disease.Biomedicines. 2024 Mar 14;12(3):657. doi: 10.3390/biomedicines12030657. Biomedicines. 2024. PMID: 38540270 Free PMC article. Review.
-
Long-term functional alterations following prenatal GLP-1R activation.Neurotoxicol Teratol. 2021 Sep-Oct;87:106984. doi: 10.1016/j.ntt.2021.106984. Epub 2021 Apr 20. Neurotoxicol Teratol. 2021. PMID: 33864929 Free PMC article.
-
Hematopoietic cell- versus enterocyte-derived dipeptidyl peptidase-4 differentially regulates triglyceride excursion in mice.JCI Insight. 2020 Aug 20;5(16):e140418. doi: 10.1172/jci.insight.140418. JCI Insight. 2020. PMID: 32663193 Free PMC article.
-
Glucagon-like peptide 1 (GLP-1).Mol Metab. 2019 Dec;30:72-130. doi: 10.1016/j.molmet.2019.09.010. Epub 2019 Sep 30. Mol Metab. 2019. PMID: 31767182 Free PMC article. Review.
-
Population pharmacokinetics of exenatide.Br J Clin Pharmacol. 2017 Mar;83(3):517-526. doi: 10.1111/bcp.13135. Epub 2016 Nov 16. Br J Clin Pharmacol. 2017. PMID: 27650681 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases